跳至主要内容
临床试验/NCT00522782
NCT00522782已完成4 期

Phase IV Study of the Effect of Nebulized Budesonide on Exhaled Nitric Oxide in Children, Four to Six Years of Age, With Asthma

AAADRS Clinical Research Center1 个研究点 分布在 1 个国家目标入组 16 人开始时间: 2007年8月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
16
试验地点
1
主要终点
Exhaled breath nitric oxide pre- to post treatment

研究概览

简要总结

To study the improvement in airway inflammation in children with asthma non-invasively with exhaled breath NO, a marker of inflammation, after therapy with nebulized budesonide as 0.5mg daily.

详细描述

Comparisons will be made before and after 2 week therapy of nebulized budesonide in children not on prior anti-inflammatory medications.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
4 Years 至 6 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Asthma diagnosis previously for 6 months
  • Past asthma medication without change for previous 6 months
  • Increased NO levels and ability to perform maneuver
  • ICF signed by parents

排除标准

  • Systemic steroids in past 60 days,inhaled/nebulized steroids in past 4 weeks
  • Hospitalization within 3 months
  • Upper or lower airways active infection or cigarette smoke direct exposure
  • Use of other asthma medications other than bronchodilators one month prior and during the trial
  • Noncompliance

研究组 & 干预措施

A

Active Comparator

Nebulized budesonide

干预措施: Nebulized Budesonide (Drug)

A

Active Comparator

Nebulized budesonide

干预措施: Nitric Oxide Analyzer (Device)

结局指标

主要结局

Exhaled breath nitric oxide pre- to post treatment

时间窗: two weeks

次要结局

  • Spirometry with peak flow measurements and daily diary scores(two weeks)

研究者

发起方
AAADRS Clinical Research Center
申办方类型
Other

研究点 (1)

Loading locations...

相似试验

Effect of Budesonide on Exhaled Nitric Oxide in... | 临床试验